WebBiosplice Therapeutics. Biosplice Therapeutics is an American pharmaceutical company engaged in the development of alternative splicing technologies. Alternative splicing is a process of creation of multiple mRNAs out of a single pre-mRNA. The company asserts that medicines that can harness this process will help cure musculoskeletal, ummune ... WebJun 18, 2024 · Biosplice Therapeutics, Inc. ClinicalTrials.gov Identifier: NCT04931667 Other Study ID Numbers: SM04690-OA-17 : First Posted: June 18, 2024 Key Record Dates: Last Update Posted: January 10, 2024 Last Verified: December 2024 Individual Participant Data (IPD) Sharing Statement: Plan to Share IPD: No
Eddy Lee - SVP CMC - Turning Point Therapeutics
WebApr 15, 2024 · SAN DIEGO, April 15, 2024 (GLOBE NEWSWIRE) -- Biosplice Therapeutics, Inc. ("Biosplice"), a clinical-stage biotechnology company pioneering therapeutics based on alternative pre-mRNA splicing for ... WebBiosplice contact info: Phone number: (858) 926-2900 Website: www.biosplice.com What does Biosplice do? Based in San Diego, CA, Biosplice is developing small-molecule … flags as a goal towards globalism
Ramkrishna Reddy Vakiti, PhD - Senior Scientist I, Medicinal
WebSep 15, 2024 · SAN DIEGO and CHENGDU, China, Sept. 15, 2024 (GLOBE NEWSWIRE) -- Biosplice Therapeutics, Inc. (“Biosplice”), a clinical-stage biotechnology company pioneering therapeutics based on CLK/DYRK ... Webinclude advancing age, female sex, obesity, and prior trauma.6 The burden of OA is both clinically significant and economically impactful with average annual medical costs and outpatient physician visits per patient being WebJan 2024 - Mar 20241 year 3 months. San Diego, California, United States. Biosplice Therapeutics is developing first-in-class, small-molecule … canon f 158 200 driver win 10 64 bit